Showing results (411-420 of 476) with videos related to

Sort By:
Pageof 48
International Journal of Spine Surgery|October 3, 2018
Long-Term Clinical Experience with Selectively Constrained SECURE-C Cervical Artificial Disc for 1-Level Cervical Disc Disease: Results from Seven-Year Follow-Up of a Prospective, Randomized, Controlled Investigational Device Exemption Clinical TrialAlexander Vaccaro, William Beutler, Walter Peppelman, et al.
Cancer Letters|May 7, 1998
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomasE M Hartenbach, T A Olson, J J Goswitz, et al.
American Journal of Obstetrics and Gynecology|January 1, 1992
Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomyS A Elg, Y Yu, L F Carson, et al.
Oncogene|November 5, 2013
Alterations in chromatin accessibility and DNA methylation in clear cell renal cell carcinomaM J Buck, L M Raaijmakers, S Ramakrishnan, et al.
Cancer Research|August 1, 1991
Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cellsF J Xu, Y H Yu, B Y Li, et al.
Gene Therapy|September 17, 2010
AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancerI V Subramanian, S Devineni, R Ghebre, et al.
Molecular Immunology|April 13, 2024
SHIP inhibition mediates select TREM2-induced microglial functionsGautham S Ramakrishnan, William L Berry, Angela Pacherille, et al.
Cell Death & Disease|January 8, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cellsShivam Vora, Saptarshi Chatterjee, Ariel Andrew, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1976
Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoidG P Talwar, N C Sharma, S K Dubey, et al.
Journal of Cellular Physiology|September 1, 1994
Mouse fibroblasts defective in thrombin mitogenesis possess functional proteolytically activated receptor for thrombin: requirement for a second signaling pathwayD W Kim, F Wang, S Ramakrishnan, et al.
Pageof 48